Construction delays, market share and renewable fuel programs: Here's what led Vertex Energy to file for bankruptcy protection.

Radio 2 has launched a service for mobile phone users. Listeners on the move can now access schedule information, features, competitions, and view the Radio 2 studio webcams via their internet ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

Boston-based Vertex Pharmaceuticals, maker of a suite of cystic fibrosis (CF) drugs, is aggressively expanding its drug development portfolio with the acquisition of Semma Therapeutics ...

The vertex shader is used to transform the attributes of vertices (points of a triangle) such as color, texture, position and direction from the original color space to the display space.

The Federal Communications Commission or FCC has temporarily authorized Elon Musk-led SpaceX and T-Mobile U.S. (NASDAQ:TMUS) ...

HOUSTON, September 06, 2024--(BUSINESS WIRE)--Vertex Energy, Inc. (NASDAQ ... the future production of the Company’s Mobile Refinery; anticipated and unforeseen events which could reduce future ...

Novo Nordisk remains a no-brainer for healthcare investors. Six reasons to buy this biotech stock Keith Speights (Vertex Pharmaceuticals): Currently, Vertex Pharmaceuticals has one blockbuster ...

If you need an amplifier, [Hans Rosenberg] has some advice. Don’t design your own; grab cheap and tiny RF amplifier modules and put them on a PCB that fits your needs. These are the ...

Commissions do not affect our editors' opinions or evaluations. Mobile check deposit can make adding money to your bank account quick and easy, without having to pay a visit to a branch.

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than ...

Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.